Industries - Biomarkers Market Analysis by Type (Safety, Validation, Efficacy), by Application (Drug Discovery & Development, Diagnostic, Personalized Medicine), by Disease (Cancer, Cardiovascular Diseases), and by Region – Forecast to 2025

Ablation Technology Market Analysis

Biomarkers Market Analysis by Type (Safety, Validation, Efficacy), by Application (Drug Discovery & Development, Diagnostic, Personalized Medicine), by Disease (Cancer, Cardiovascular Diseases), and by Region – Forecast to 2025
October 2020

SKU: N/A Category:
Clear
  • Description
  • Additional information
  • Enquire about

Description

Biomarkers Market Analysis by Type (Safety, Validation, Efficacy), by Application (Drug Discovery & Development, Diagnostic, Personalized Medicine), by Disease (Cancer, Cardiovascular Diseases), and by Region - Forecast to 2025

Published: October 2020 | Historical Data: 2017-2019 | Base Year: 2019
SKU:ICI-HC-1037 | Number of Pages: 134 | Category: Clinical Diagnostics

The global biomarkers market size is estimated to be USD 46.13 billion in 2019 and is expected to witness a CAGR of 13.3% during the forecast period. Increasing number of diagnostic tests, growing R&D investment, growing clinical trials in the developing nations, rise in cancer prevalence are the major factors boosting the global market growth. However, the high cost of biomarkers, improper reimbursement scenario, and problems associated with collection & storage of samples are some of the factors hindering the market growth.

Biomarkers Market

By Type

Based on type, the biomarkers market is segmented into safety, efficacy, and validation biomarkers. In 2019, the safety biomarkers segment accounted for the largest revenue share owing to its high use in the clinical and pre-clinical trials of the various drugs. The validation biomarker segment is projected to grow at a lucrative CAGR during the forecast period due to the ongoing investments biopharmaceutical R&D sector, with an aim to predict the therapeutic failure of the drugs.

By Application

Based on application, the market is categorized into drug discovery & development, personalized medicine, diagnostics, and others. In 2019, the drug discovery & development segment accounted for the highest revenue share due to the rising importance of biomarkers in the drug development stage, especially for making targeted therapy for the patients. Personalized medicine is projected to grow at the highest CAGR during the forecast period, owing to the increased knowledge among the customer base and rise in the number of regulatory approvals aiding cancer diagnosis.

By Disease

Based on disease, the market is categorized majorly into cancer, cardiovascular diseases, neurological diseases, immunological diseases, and others. The cancer segment was the highest revenue-generating segment in 2019 and is projected to dominate the market till 2025, owing to the high use of biomarkers for cancer diagnostics and demand for highly precise diagnostic tools. Cardiovascular segment is projected to grow at the highest CAGR over the forecast period. The growth for cardiovascular disease can be attributed to factors such as rise in the demand for the personalized medicines, development of new biomarkers for cardiovascular diseases, and rising incidence & prevalence of the cardiovascular disease.

Regional Insights

In 2019, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of major companies dealing in biomarkers in the region, new product launches, well-developed healthcare infrastructure, and high investment for cancer research. Asia Pacific is projected to exhibit the fastest CAGR over the forecast period owing to the factors such as cost advantage for conducting clinical trials as compared to developed regions, rise in R&D investments, strategic collaborations, and regional expansion by the companies.

North America Biomarkers Market Size (2017-2025), USD Billion

North America Biomarkers Market

Competitor Insights

Some of the key players in the biomarkers market are Siemens Healthineers (Germany); F. Hoffmann-La Roche (Switzerland); Johnson & Johnson (U.S.); Abbott (U.S.); QIAGEN N.V. (Netherlands); Agilent Technologies (U.S.); Bio-Rad Laboratories (U.S.); PerkinElmer, Inc. (U.S.); Epigenomics AG (Germany); Thermo Fisher Scientific, Inc. (U.S.); and Enzo Biochem, Inc. (U.S.). The leading players operating in the biomarkers industry are adopting various strategies such as new product development, regional expansion in Asian countries, and mergers and acquisitions to capture a major share in the market.

 

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2017 to 2025. The biomarkers market report is categorized into the following segments and subsegments:

Biomarkers Market, By Type (Revenue, 2017 – 2025, USD Billion)

  • Safety
  • Efficacy
  • Validation

Biomarkers Market, By Application (Revenue, 2017 – 2025, USD Billion)

  • Drug Discovery & Development
  • Diagnostic
  • Personalized Medicine
  • Others

Biomarkers Market, By Disease (Revenue, 2017 – 2025, USD Billion)

  • Neurological Diseases
  • Cancer
  • Immunological Diseases
  • Cardiovascular Diseases disease
  • Others

Biomarkers Market, By Region (Revenue, 2017 – 2025, USD Billion)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia
    • South Korea
    • India
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Biomarkers Market Report:

Key Parameters Details
Data Availability 2017-2025
Historical Years 2017-2019
Base Year Considered 2019
Forecast Period 2019-2025
Company Profiles 10
Companies Considered (Across Value Chain) >25
Value Units Value in USD and CAGR in %
Market Segments Type, Application, and Disease
Regional Coverage North America (U.S. and Canada), Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe), Asia Pacific (China, Japan, Australia, India, South Korea, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), and the Middle East & Africa (South Africa, Saudi Arabia, Rest of MEA)
Key Market Players Siemens Healthineers (Germany); F. Hoffmann-La Roche (Switzerland); Johnson & Johnson (U.S.); Abbott (U.S.); QIAGEN N.V. (Netherlands); Agilent Technologies (U.S.); Bio-Rad Laboratories (U.S.); PerkinElmer, Inc. (U.S.); Epigenomics AG (Germany); Thermo Fisher Scientific, Inc. (U.S.); and Enzo Biochem, Inc. (U.S.)
Custom Analysis Customization up to 60 analyst hours

Biomarkers Market, By Type (Revenue, 2017 – 2025, USD Billion)

  • Safety
  • Efficacy
  • Validation

Biomarkers Market, By Application (Revenue, 2017 – 2025, USD Billion)

  • Drug Discovery & Development
  • Diagnostic
  • Personalized Medicine
  • Others

Biomarkers Market, By Disease (Revenue, 2017 – 2025, USD Billion)

  • Neurological Diseases
  • Cancer
  • Immunological Diseases
  • Cardiovascular Diseases disease
  • Others

Biomarkers Market, By Region (Revenue, 2017 – 2025, USD Billion)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia
    • South Korea
    • India
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA
1. Research Methodology
 1.1. Research Objective
 1.2. Study Scope: Market Segments
 1.3. Study Timeframe, Limitations & Currency
 1.4. Domain-Assisted Cognition (DAC) Framework
  1.4.1. Three-stage Research Methodology
   1.4.1.1. Understand Ecosystem
    1.4.1.1.1. Secondary Research
    1.4.1.1.2. Primary Research
    1.4.1.1.3. Internal Repository
   1.4.1.2. Synthesize Information
    1.4.1.2.1. Data Analysis
    1.4.1.2.2. Data Triangulation
   1.4.1.3. Predict/Project Growth
    1.4.1.3.1. Market Size Estimation
     1.4.1.3.1.1. Bottom-up Approach
     1.4.1.3.1.2. Top-down Approach
    1.4.1.3.2. Data Validation
  1.4.2. Two-stage Quality Check Mechanism
   1.4.2.1. Inspection & Reporting
   1.4.2.2. Quality Audit
2. Market Summary
 2.1. Market Definition & Market Landscape
 2.2. Market Segment Snapshot
 2.3. Geographic Market Snapshot
3. Market Dynamics
 3.1. Market Driver Analysis
  3.1.1. Increasing number of diagnostic tests
  3.1.2. Rise in R&D investment
  3.1.3. Reducing prices of clinical trials in emerging markets
  3.1.4. Growing cases of chronic diseases
 3.2. Market Restraint Analysis
  3.2.1. Inadequate collection & sample storage coupled with information error & misplacement
  3.2.2. Frequent sample contamination error
 3.3. Market Opportunities
  3.3.1. Application of biomarkers in unexplored healthcare verticals
  3.3.2. Market growth of emerging economies
4. Industry Outlook
 4.1. Key Market Trends
 4.2. Value Chain Analysis
 4.3. Porter’s 5 Forces Analysis
 4.4. Pricing Analysis (2017-2019)
 4.5. Product Benchmarking
5. Covid-19 Impact and Deviation Analysis
 5.1. Covid-19 Prevalence Analysis
 5.2. Key Market Trends
 5.3. Market Size Deviation Analysis (2020-2025)
6. Biomarkers Market Size and Forecast, by Type (2017-2025), USD Million
 6.1. Safety
 6.2. Efficacy
 6.3. Validation
7. Biomarkers Market Size and Forecast, by Application (2017-2025), USD Million
 7.1. Diagnostic
 7.2. Personalized Medicine
 7.3. Drug Development
 7.4. Others
8. Biomarkers Market Size and Forecast, by Disease (2017-2025), USD Million
 8.1. Cancer
 8.2. Cardiovascular Diseases disease
 8.3. Immunological Diseases
 8.4. Neurological Diseases
 8.5. Others
9. Biomarkers Market, Regional Analysis (2017-2025), USD Million
 9.1. North America
  9.1.1. Introduction
   9.1.1.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.1.1.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.1.1.3. Market Size & Forecast, by Disease (2017-2025), USD Million
   9.1.1.4. Market Size & Forecast, by Country (2017-2025), USD Million
  9.1.2. U.S.
   9.1.2.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.1.2.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.1.2.3. Market Size & Forecast, by Disease (2017-2025), USD Million
  9.1.3. Canada
   9.1.3.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.1.3.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.1.3.3. Market Size & Forecast, by Disease (2017-2025), USD Million
 9.2. Europe
  9.2.1. Introduction
   9.2.1.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.2.1.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.2.1.3. Market Size & Forecast, by Disease (2017-2025), USD Million
   9.2.1.4. Market Size & Forecast, by Country (2017-2025), USD Million
  9.2.2. Germany
   9.2.2.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.2.2.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.2.2.3. Market Size & Forecast, by Disease (2017-2025), USD Million
  9.2.3. UK
   9.2.3.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.2.3.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.2.3.3. Market Size & Forecast, by Disease (2017-2025), USD Million
  9.2.4. France
   9.2.4.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.2.4.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.2.4.3. Market Size & Forecast, by Disease (2017-2025), USD Million
  9.2.5. Spain
   9.2.5.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.2.5.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.2.5.3. Market Size & Forecast, by Disease (2017-2025), USD Million
  9.2.6. Italy
   9.2.6.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.2.6.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.2.6.3. Market Size & Forecast, by Disease (2017-2025), USD Million
  9.2.7. Russia
   9.2.7.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.2.7.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.2.7.3. Market Size & Forecast, by Disease (2017-2025), USD Million
  9.2.8. Rest of Europe
   9.2.8.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.2.8.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.2.8.3. Market Size & Forecast, by Disease (2017-2025), USD Million
 9.3. Asia Pacific (APAC)
  9.3.1. Introduction
   9.3.1.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.3.1.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.3.1.3. Market Size & Forecast, by Disease (2017-2025), USD Million
   9.3.1.4. Market Size & Forecast, by Country (2017-2025), USD Million
  9.3.2. China
   9.3.2.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.3.2.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.3.2.3. Market Size & Forecast, by Disease (2017-2025), USD Million
  9.3.3. Japan
   9.3.3.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.3.3.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.3.3.3. Market Size & Forecast, by Disease (2017-2025), USD Million
  9.3.4. India
   9.3.4.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.3.4.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.3.4.3. Market Size & Forecast, by Disease (2017-2025), USD Million
  9.3.5. Australia
   9.3.5.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.3.5.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.3.5.3. Market Size & Forecast, by Disease (2017-2025), USD Million
  9.3.6. South Korea
   9.3.6.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.3.6.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.3.6.3. Market Size & Forecast, by Disease (2017-2025), USD Million
  9.3.7. Rest of Asia Pacific
   9.3.7.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.3.7.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.3.7.3. Market Size & Forecast, by Disease (2017-2025), USD Million
 9.4. Latin America (LATAM)
  9.4.1. Introduction
   9.4.1.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.4.1.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.4.1.3. Market Size & Forecast, by Disease (2017-2025), USD Million
   9.4.1.4. Market Size & Forecast, by Country (2017-2025), USD Million
  9.4.2. Brazil
   9.4.2.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.4.2.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.4.2.3. Market Size & Forecast, by Disease (2017-2025), USD Million
  9.4.3. Mexico
   9.4.3.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.4.3.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.4.3.3. Market Size & Forecast, by Disease (2017-2025), USD Million
  9.4.4. Argentina
   9.4.4.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.4.4.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.4.4.3. Market Size & Forecast, by Disease (2017-2025), USD Million
  9.4.5. Rest of LATAM
   9.4.5.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.4.5.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.4.5.3. Market Size & Forecast, by Disease (2017-2025), USD Million
 9.5. Middle East & Africa (MEA)
  9.5.1. Introduction
   9.5.1.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.5.1.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.5.1.3. Market Size & Forecast, by Disease (2017-2025), USD Million
   9.5.1.4. Market Size & Forecast, by Country (2017-2025), USD Million
  9.5.2. South Africa
   9.5.2.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.5.2.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.5.2.3. Market Size & Forecast, by Disease (2017-2025), USD Million
  9.5.3. Saudi Arabia
   9.5.3.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.5.3.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.5.3.3. Market Size & Forecast, by Disease (2017-2025), USD Million
  9.5.4. Rest of MEA
   9.5.4.1. Market Size & Forecast, by Type (2017-2025), USD Million
   9.5.4.2. Market Size & Forecast, by Application (2017-2025), USD Million
   9.5.4.3. Market Size & Forecast, by Disease (2017-2025), USD Million
10. Competitor Analysis
 10.1. Market Player Comparison
 10.2. Product-wise Player Mapping
 10.3. Region-wise Player Mapping
 10.4. Market Share Analysis
 10.5. Market Position Analysis
 10.6. Recent Development Analysis
11. Company Profiles
 11.1. Siemens Healthineers (Germany)
  11.1.1. Company Overview
  11.1.2. Company Financials
  11.1.3. Product Portfolio
  11.1.4. Recent Developments
 11.2. F. Hoffmann-La Roche (Switzerland)
  11.2.1. Company Overview
  11.2.2. Company Financials
  11.2.3. Product Portfolio
  11.2.4. Recent Developments
 11.3. Johnson & Johnson (US)
  11.3.1. Company Overview
  11.3.2. Company Financials
  11.3.3. Product Portfolio
  11.3.4. Recent Developments
 11.4. Abbott (US)
  11.4.1. Company Overview
  11.4.2. Company Financials
  11.4.3. Product Portfolio
  11.4.4. Recent Developments
 11.5. QIAGEN N.V. (Netherlands)
  11.5.1. Company Overview
  11.5.2. Company Financials
  11.5.3. Product Portfolio
  11.5.4. Recent Developments
 11.6. Agilent Technologies (US)
  11.6.1. Company Overview
  11.6.2. Company Financials
  11.6.3. Product Portfolio
  11.6.4. Recent Developments
 11.7. Bio-Rad Laboratories (US)
  11.7.1. Company Overview
  11.7.2. Company Financials
  11.7.3. Product Portfolio
  11.7.4. Recent Developments
 11.8. PerkinElmer, Inc. (U.S.)
  11.8.1. Company Overview
  11.8.2. Company Financials
  11.8.3. Product Portfolio
  11.8.4. Recent Developments
 11.9. Epigenomics AG (Germany)
  11.9.1. Company Overview
  11.9.2. Company Financials
  11.9.3. Product Portfolio
  11.9.4. Recent Developments
 11.10. Thermo Fisher Scientific, Inc. (U.S.)
  11.10.1. Company Overview
  11.10.2. Company Financials
  11.10.3. Product Portfolio
  11.10.4. Recent Developments
(Note: Financials are captured for public listed companies)

Key questions addressed by the research report-

  1. What are the current market trends and future market forecast from 2019 to 2025 for biomarkers market?
  2. What are the market dynamics and probable opportunities for market players during the forecast period?
  3. Initiatives undertaken my market players to address the COVID-19 impact to sustain in the competitive market.
  4. Which geographies have immense opportunities in different segments of the biomarkers market?
  5. What are the recent strategies adopted by market players such as product launch, partnership, agreement, collaboration, merger & acquisition, and geographical expansion?


    Have any question? Check your free sample before purchase or connect with our expert.

    Additional information

    Licensing Types

    , , ,

    Enquire about Biomarkers Market Analysis by Type (Safety, Validation, Efficacy), by Application (Drug Discovery & Development, Diagnostic, Personalized Medicine), by Disease (Cancer, Cardiovascular Diseases), and by Region - Forecast to 2025